Skip to content
Important: This site presents data from the FDA Adverse Event Reporting System (FAERS). A report does not mean the drug caused the event. Full disclaimer.

NICARDIPINE vs NILOTINIB: Which Drug Is Safer?

Boost Your Natural Energy & Metabolism

Mitolyn — 6 exotic plants to unlock your body's fat-burning power. 90-day guarantee.

Try Mitolyn Now

NICARDIPINE vs NILOTINIB: Safety Overview

Metric NICARDIPINE NILOTINIB
Total FAERS Reports 2,317 23,171
Deaths Reported 182 4,543
Death Rate 7.9% 19.6%
Hospitalizations 1,073 4,846
Average Patient Age 56.7 yrs 56.5 yrs
% Female Patients 60.8% 47.7%
FDA Approval Date Apr 10, 2024 Dec 15, 2025
Manufacturer Amici Pharma Inc Novadoz Pharmaceuticals LLC
Route ORAL ORAL
Marketing Status Discontinued Prescription